Counteracting Radio-Resistance Using the Optimization of Radiotherapy.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Mar 2020
Historique:
received: 28 02 2020
accepted: 03 03 2020
entrez: 11 3 2020
pubmed: 11 3 2020
medline: 2 12 2020
Statut: epublish

Résumé

Radiotherapy is an essential component of cancer therapy and remains one of the most (cost-) effective treatment options available [...].

Identifiants

pubmed: 32150868
pii: ijms21051767
doi: 10.3390/ijms21051767
pmc: PMC7084332
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2019 Jul 25;20(15):
pubmed: 31349558
Int J Mol Sci. 2019 Dec 24;21(1):
pubmed: 31878191
Int J Mol Sci. 2020 Jan 31;21(3):
pubmed: 32023866
Int J Mol Sci. 2019 Sep 14;20(18):
pubmed: 31540114
Int J Mol Sci. 2019 Aug 25;20(17):
pubmed: 31450688

Auteurs

François Chevalier (F)

UMR6252 CIMAP, CEA-CNRS-ENSICAEN-Université de Caen Normandie, 14000 Caen, France.
LARIA, iRCM, François Jacob Institute, DRF-CEA, 14000 Caen, France.
ARCHADE Research Community, 14000 Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH